COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,523 Articles (22,380 medRxiv, 8,143 bioRxiv)

Most recent first Previous |  Page 290: Articles 2891-2900  | Next

Host factor PLAC8 is required for pancreas infection by SARS-CoV-2
Ibarguen Gonzalez, L., Heller, S., DeDiego, M. L., Lopez-Garcia, D., Gomez-Valero, A. M., Barth, T. F., Gallego, P., Fernandez-Cardenas, I., Alzate-Pinol, S., Crespi, C., Mena-Guerrero, J. A., Cisneros-Barroso, M. E., Ugalde, A. P., Bretones, G., Steenblock, C., Kleger, A., Barcelo, C.
10.1101/2023.08.18.553908 — Posted: 2023-08-21
Modeling geographic vaccination strategies for COVID-19 in Norway
Chan, L. Y. H., Ro, G., Midtbo, J. E., Di Ruscio, F., Watle, S. S. V., Juvet, L. K., Littmann, J., Aavitsland, P., Nygard, K. M., Berg, A. S., Bukholm, G., Kristoffersen, A. B., Engo-Monsen, K., Engebretsen, S., Swanson, D., Palomares, A. D.-L., Lindstrom, J. C., Frigessi, A., de Blasio, B. F.
10.1101/2023.08.16.23294112 — Posted: 2023-08-21
Genome-wide Bioinformatics Analysis of Human Protease Specificity Identified Potential Cathepsin L Cleavage Site at K790 Position of the SARS-CoV-2 Spike Glycoprotein
Matveev, E. V., Ponomarev, G. V., Kazanov, M. D.
10.1101/2023.08.19.553950 — Posted: 2023-08-21
Unraveling COVID-19: Descriptive Analytics in a Middle-Income Country, Paving the Path Forward
Bansilan, N. P., Rabajante, J. F.
10.1101/2023.08.16.23294160 — Posted: 2023-08-20
Strategic use of SARS-CoV-2 wastewater concentration data could enhance, but not replace, high-resolution community prevalence survey programmes
Mills, C., Chadeau-Hyam, M., Elliott, P. L., Donnelly, C. A.
10.1101/2023.08.17.23293589 — Posted: 2023-08-20
Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu
Townsend, J. A., Fapohunda, O., Wang, Z., Pham, H., Taylor, M. T., Kloss, B., Park, S. H., Opella, S. J., Aspinwall, C. A., Marty, M. T.
10.1101/2023.08.18.553902 — Posted: 2023-08-20
How reliable are estimates of key parameters in viral dynamic models?
Zitzmann, C., Ke, R., Ribeiro, R. M., Perelson, A. S.
10.1101/2023.08.17.553792 — Posted: 2023-08-18
Purification, crystallization, and preliminary structural analysis of multivalent immunogenic effector protein-anchored SARS-CoV-2 RBD
Kwon, T. H., Kim, T. G.
10.1101/2023.08.17.553661 — Posted: 2023-08-18
Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
Tamura, T., Irie, T., Deguchi, S., Yajima, H., Tsuda, M., Nasser, H., Mizuma, K., Plianchaisuk, A., Suzuki, S., Uriu, K., Begum, M. M., Shimizu, R., Jonathan, M., Suzuki, R., Kondo, T., Ito, H., Kamiyama, A., Yoshimatsu, K., Shofa, M., Hashimoto, R., Anraku, Y., Kimura, K. T., Kita, S., Sasaki, J., Sasaki-Tabata, K., Maenaka, K., Nao, N., Wang, L., Oda, Y., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Saito, A., Matsuno, K., Ito, J., Tanaka, S., Sato, K., Hashiguchi, T., Takayama, K., Fukuhara, T.
10.1101/2023.08.16.553332 — Posted: 2023-08-17
Assembly of SARS-CoV-2 ribonucleosomes by truncated N* variant of the nucleocapsid protein
Adly, A., Bi, M., Carlson, C., Syed, A. M., Ciling, A., Doudna, J., Cheng, Y., Morgan, D. O.
10.1101/2023.08.16.553581 — Posted: 2023-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).